EU regulators set Oct. 3 deadline for Eli Lilly, Novartis deal

BRUSSELS, Sept 1 (Reuters) - European Union competition regulators have until Oct. 3 to decide whether to approve U.S. drugmaker Eli Lilly and Co's $5.4 billion bid for Swiss peer Novartis's animal health business.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.